Will New Cellular Models of Parkinson’s Disease Advance Understanding of Disease and Therapy?
neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease, Nature, 2002;418:50–6.
37. Burbach JP, Smidt MP, Molecular programming of stem cells into mesodiencephalic dopaminergic neurons, Trends Neurosci, 2006;29:601–3.
38. Smidt MP, Burbach JP, How to make a mesodiencephalic dopaminergic neuron, Nat Rev Neurosci, 2007;8:21–32.
39. Van den Heuvel DM, Pasterkamp RJ, Getting connected in the dopamine system, Prog Neurobiol, 2008;85:75–93.
40. Swistowski A, Peng J, Han Y, et al., Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them, PLoS One, 2009;4:e6233.
41. Perrier AL, Tabar V, Barberi T, et al., Derivation of midbrain dopamine neurons from human embryonic stem cells, Proc Natl Acad Sci U S A, 2004;101:12543–8.
42. Chambers SM, Fasano CA, Papapetrou EP, et al., Highly
efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling, Nat Biotechnol, 2009;27:275–80.
43. Swistowski A, Peng J, Liu Q, et al., Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions, Stem Cells, 2010;28:1893–904.
44. Park IH, Arora N, Huo H, et al., Disease-specific induced pluripotent stem cells, Cell, 2008;134:877–86.
45. Soldner F, Hockemeyer D, Beard C, et al., Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors, Cell, 2009;136:964–77.
46. Hargus G, Cooper O, Deleidi M, et al., Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats, Proc Natl Acad Sci U S A, 2010;107:15921–6.
47. Gunaseeli I, Doss MX, Antzelevitch C, et al., Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery, Curr Med Chem, 2010;17:759–66.
48. Barbaric I, Gokhale PJ, Andrews PW, High-content screening of small compounds on human embryonic stem cells, Biochem Soc Trans, 2010;38:1046–50.
49. Urnov FD, Rebar EJ, Holmes MC, et al., Genome editing with engineered zinc finger nucleases, Nat Rev Genet, 2010;11:636–46.
50. Hockemeyer D, Soldner F, Beard C, et al., Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases, Nat Biotechnol, 2009;27:851–7.
51. Chung S, Leung A, Han BS, et al., Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway, Cell Stem Cell, 2009;5:646–58.
EUROPEAN NEUROLOGICAL REVIEW SUPPLEMENT
31
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39